Tingible body macrophages (TBM), long thought simply as scavengers of apoptotic lymphocytes, are located in the unique microenvironment of germinal centers in close proximity to antigen-retaining follicular dendritic cells (FDC). Observations that TBM endocytose FDCiccosomal (immune-complex coated bodies) antigen suggested that TBM might present this antigen and help regulate the germinal center reaction. To test for antigen presentation, the ovalbumin (OVA)-specific TI hybridoma, 3DO-54.8, which produces IL-2 on receiving effective presentation of OVA, were used as responders to OVA-bearing TBM. Results showed that OVA-bearing TBM failed to induce IL-2 production. Furthermore, addition of TBM to IL-2-inducing positive controls (B cells) not only failed to augment IL-2 production, but rather TBM significantly (55-90%) reduced B-cell induction of IL-2. We found that TBM were rich in prostaglandin by comparison with other nongerminal center lymph node macrophages and that addition of indomethacin to the cultures reversed the inhibitory effect of TBM. Depletion of TBM from enriched preparations, prior to addition to positive control cultures, also abrogated the inhibitory effect on IL-2 production. These data support the concept that TBM, within the unique microenvironment of germinal centers, may be specialized to downregulate the germinal center reaction.
INTRODUCTION
Macrophages represent a heterogenous population, and macrophage functions are influenced by the microenvironment in which they reside. By definition, tingible body macrophages (TBM), a subset of the mononuclear phagocytes, are unique, large phagocytic cells that reside in germinal centers of secondary *Corresponding author. lymphoid tissues (Flemming, 1885) . TBM contain many phagocytized, apoptotic cells (referred to as tingible bodies) (Flemming, 1885) in various states of degradation (Swartzendruber and Congdon, 1963 a high rate of somatic mutations, affinity maturation, induction of antibody-forming cells and memory Bcell development (Coico et al., 1983; Szakal et al., 1989; Tew et al., 1990) . Although the scavenging function of TBM in germinal centers is obvious, it has also been suggested that TBM may be important in initiating the germinal center reaction (Kamperdijk et al., 1978 (Kamperdijk et al., , 1982 .
Regarding the germinal center reaction, it has been shown that germinal center B cells are extremely effective antigen-presenting cells. Three to eight days after a booster immunization, germinal center B cells obtain antigen from FDCs in the form of immune complex coated bodibs (iccosomes) and are capable of processing and presenting the iccosomal antigen to T cells in an MHC-restricted manner Szakal et al., 1988 and that many TBM are class II positive (Smith et al., 1988) , suggest that TBM might also be able to present the FDC-derived antigen to T cells (Smith et al., 1988) . 
RESULTS

Antigen Presentation
Germinal center B cells obtain antigen from FDC for processing and presentation to T cells during a period between 3 and 8 days after booster immunization. Typically, numerous germinal center B cells (20%) were present in the TBM preparation and both TBM and germinal center B cells take up iccosomes Szakal et al., 1988) . Therefore, we reasoned that the addition of TBM-enriched cells from an OVA-immune animal to the OVA-specific Tcell hybridoma 3DO-54.8 should result in antigen presentation and IL-2 production. As shown in Table  I (Stenson and Parker, 1980) . Classically, macrophages are believed to be important accessory cells for antigen presentation Shevach, 1973a, 1973b; Unanue, 1981 (Parkhouse and Dutton, 1966 (Stenson and Parker, 1980; Goodwin and Ceuppens, 1983) .
The binding of immune complexes by macrophages stimulates phagocytosis, which in turn stimulates prostaglandin synthesis with the major product being PGE2 with smaller amounts of PGF1 (Bonney et al., 1979 ). This immune-complex stimulation may help explain the high level of prostaglandin in TBM since they may encounter immune complexes directly on the processes of FDC and in the form of iccosomes (Rouse et al., 1982a (Rouse et al., , 1982b . Interestingly, a close association between TBM and germinal center T cells has been observed (Nieuwenhuis and Opstelten, 1984, and unpublished) .
Germinal centers are sites of memory B-cell production (Coico et al., 1983) and production of memory B cells involves somatic mutation and maintenance of B cells that express high-affinity receptors for the stimulating antigen (Wysocki et al., 1986) . It has been suggested that B cells with lowaffinity antigen receptors cannot compete for antigen persisting on FDC and are clonally deleted (Wysocki et al., 1986) . The tingible bodies in TBM may represent phagocytized low-affinity B cells that have been condemned to undergo apoptosis (Manser et al., 1987; Schad and Phipps, 1988 It has also been suggested that TBM play an active role in initiating the germinal center reaction (Kamperdijk et al., 1978 (Kamperdijk et al., , 1982 . This suggestion was based on the observations that TBM initially appeared at the onset of germinal center development and that peak numbers of TBM were seen at peak germinal center development. However, in recent studies, it has been shown that TBM are not absolutely essential for germinal center development. Germinal centers can develop in old mice in the absence of TBM (Smith et al., 1990) . The data shown in this report are consistent with a regulatory role for TBM and it appears that TBM are more likely to down regulate than to stimulate the germinal center reaction.
MATERIALS AND METHODS
Animals
Ten-to sixteen-week-old female Balb/C (H-2d) mice were purchased from Charles River Laboratories (Wilmington, MA). The animals were housed under pathogen-free conditions in standard cages equipped with filter tops and allowed food and water ad libitum.
Cell Lines and mAb
The TH1 cell hybridoma 3DO-54.8 was a gift from J. (Flotte et al., 1983; Smith et al., 1990) , and, in addition, TBM also express Thy-1 (Smith et al., 1988) . Consequently, TBM can be selectively removed from TBM-enriched cell populations using anti-Mac-2 and anti-Thy-1 on immunomagnetic beads (Dynal, Great Neck, NY). The beads were purchased precoated with Fc-specific sheep antirat IgG. The beads were washed five times, incubated with a cocktail of anti-Mac-2 (1:4 dilution) and mouse anti-rat Thy-1 (1:20) for 1 hr at 4C with intermittent agitation, and gently washed three times with HBSS. The beads were then incubated with the Mac-2/Thy-1-treated TBM-enricheff preparation at a bead-to-cell ratio of 40:1 for 30 min on ice with gentle intermittent agitation. Following incubation, the Dynabead rosetted TBM were removed using the Dynal magnetic chamber. The remaining cells were collected with a Pasteur pipette, washed, and adjusted to 2 105 cells/ 50/zl in complete media. This preparation was used as the TBM-depleted population.
IL-2 Assay for Antigen Presentation
Antigen presentation was assessed using an assay system similar to the one originally described by Shimonkevitz et al. (1983) . In this system, the OVAspecific Try-cell hybridoma 3DO-54.8 (3DO) will produce the lymphokine IL-2 when cocultured with OVA and a source of antigen-presenting cells. The production of IL-2 can then be quantitated by transferring aliquots of media from the cocultured cells to the IL-2-dependent T-cell line CTLL. idase activity was inhibited according to the method of Herzog and Miller (1972) .
Depletion of TBM Relieves Suppression of IL-2
Activity
If the TBM were responsible for depressing the IL-2 production, depletion of the TBM from the enriched preparation prior to addition to the control cultures should alleviate the suppression. Results from a representative experiment using TBM-depleted cells are shown in Fig. 2 . Addition of the TBM-enriched population to positive controls resulted in dramatic depression of IL-2 production--about 10% of positive control cultures. Addition of indomethacin to cultures containing TBM-enriched cells resulted in a restoration of most of the IL-2 activity. Furthermore, depletion of TBM from TBM-enriched populations restored IL-2 production to a level insignificantly less than that of the positive controls.
